Gapicomine

From Self-sufficiency
Revision as of 15:48, 19 September 2010 by Jontas (Talk | contribs) (1 revision)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Gapicomine
File:Gapicomine.png
Systematic (IUPAC) name
1-Pyridin-4-yl-N-(pyridin-4-ylmethyl)methanamine
Clinical data
Routes of
administration		 oral (tablet)
Legal status
Legal status
  • off market (was used in EU countries)
Identifiers
CAS Number 1539-39-5
ATC code none
PubChem CID 68955
Chemical data
Formula C12H13N3
Molar mass 199.25 g/mol[[Script error: No such module "String".]]
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Gapicomine (INN) is a coronary vasodilator. It has been withdrawn from the market in the countries it was used in.[1]

Also, gapicomine is a major component in the drug bicordin.[2]

History

Gapicomine was discovered in 1970 by Polish chemist Stanisław Biniecki. It was first published about in an article of The Polish Journal of Medicine and Pharmacy describing the derivative drug bicordin in 1974.[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


Nitrates/nitrovasodilators
Quinolone vasodilators
Others


30px This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it.
pl:Gapikomina
  1. ↑ "Gapicomine Monograph, The Index Nominum". Retrieved 2008-03-31. 
  2. ↑ "Bicordin, PubChem". Retrieved 2008-03-31. 
  3. ↑ Samochowiec L, Wójcicki J, Gregorczyk K, Szmatloch E. (1974). "Bicordin--a new drug in the treatment of coronary heart disease". Mater Med Pol. 6 (4): 298–300. PMID 4453155. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Gapicomine&oldid=22582"